<Record>
<Term>Papillomavirus Vaccines</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Immunologic Factor</SemanticType>
<ParentTerm>Viral Vaccines</ParentTerm>
<ClassificationPath>Complex Mixtures/Biological Products/Vaccines/Viral Vaccines/Papillomavirus Vaccines</ClassificationPath>
<BroaderTerm>Papillomavirus Vaccines</BroaderTerm>
<BroaderTerm>Biological Products</BroaderTerm>
<BroaderTerm>Viral Vaccines</BroaderTerm>
<BroaderTerm>Vaccines</BroaderTerm>
<BroaderTerm>Complex Mixtures</BroaderTerm>
<Synonym>Papillomavirus Vaccines</Synonym>
<Synonym>Human Papillomavirus Vaccines</Synonym>
<Synonym>Human Papilloma Virus Vaccines</Synonym>
<Synonym>HPV Vaccines</Synonym>
<Description>Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.</Description>
<Source>MeSH</Source>
</Record>
